These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26753621)

  • 1. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.
    Bianchi-Frias D; Basom R; Delrow JJ; Coleman IM; Dakhova O; Qu X; Fang M; Franco OE; Ericson NG; Bielas JH; Hayward SW; True L; Morrissey C; Brown L; Bhowmick NA; Rowley D; Ittmann M; Nelson PS
    Mol Cancer Res; 2016 Apr; 14(4):374-84. PubMed ID: 26753621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.
    Bianchi-Frias D; Hernandez SA; Coleman R; Wu H; Nelson PS
    Mol Cancer Res; 2015 Feb; 13(2):339-47. PubMed ID: 25298407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas.
    Ribeiro FR; Henrique R; Hektoen M; Berg M; Jerónimo C; Teixeira MR; Lothe RA
    Mol Cancer; 2006 Sep; 5():33. PubMed ID: 16952311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
    Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
    Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic aberrations in prostate cancer by microarray analysis.
    Saramäki OR; Porkka KP; Vessella RL; Visakorpi T
    Int J Cancer; 2006 Sep; 119(6):1322-9. PubMed ID: 16642477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
    Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
    Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
    Watson SK; Woolcock BW; Fee JN; Bainbridge TC; Webber D; Kinahan TJ; Lam WL; Vielkind JR
    Prostate; 2009 Jun; 69(9):961-75. PubMed ID: 19267368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.
    Williams JL; Greer PA; Squire JA
    Cancer Genet; 2014; 207(10-12):474-88. PubMed ID: 25434580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of progression of prostate cancer.
    Nupponen N; Visakorpi T
    Eur Urol; 1999; 35(5-6):351-4. PubMed ID: 10325488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer.
    Laufer-Amorim R; Fonseca-Alves CE; Villacis RAR; Linde SAD; Carvalho M; Larsen SJ; Marchi FA; Rogatto SR
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.